A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.
about
Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.Pediatric Low-Grade Gliomas: Next Biologically Driven Steps.Dramatic clinical and radiographic response to BRAF inhibition in a patient with progressive disseminated optic pathway glioma refractory to MEK inhibition.Current Development Status of MEK Inhibitors.Neurofibromatosis type 1 and optic pathway glioma: Molecular interplay and therapeutic insights.Neurological update: gliomas and other primary brain tumours in adults.Pediatric High Grade Gliomas in the Context of Cancer Predisposition Syndromes.Quick and sustained clinical response to MEK inhibitor I in a NF1 patient with neurofibromas
P2860
Q36771546-F7C3299A-1880-4F26-8E71-856C0D7266A0Q46667195-89478DFD-1DCD-4B7B-8BA7-50E7AA8CAAA8Q47640185-B756646D-9928-40A1-96AE-4C130BC8461BQ47735535-03A30B1D-BBE7-40B8-BD11-EF4959AA23C9Q47887929-2514DE14-7567-4F55-9066-F1C401107FB8Q47989137-1184869E-0619-4502-A3B7-04ADB2FAD73BQ55277238-08DA7CCF-24FC-4F5C-9583-C38E52E7976BQ58699185-7385E888-8A1A-4B6A-B17C-7E713C796C88
P2860
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A phase I trial of the MEK inh ...... Tumor Consortium (PBTC) study.
@en
A phase I trial of the MEK inhibitor selumetinib
@nl
type
label
A phase I trial of the MEK inh ...... Tumor Consortium (PBTC) study.
@en
A phase I trial of the MEK inhibitor selumetinib
@nl
prefLabel
A phase I trial of the MEK inh ...... Tumor Consortium (PBTC) study.
@en
A phase I trial of the MEK inhibitor selumetinib
@nl
P2093
P2860
P356
P1433
P1476
A phase I trial of the MEK inh ...... Tumor Consortium (PBTC) study.
@en
P2093
Anuradha Banerjee
Arie Perry
Arzu Onar-Thomas
Clinton F Stewart
David Turner
Ian F Pollack
Ibrahim Qaddoumi
James M Boyett
Jason Fangusaro
Joanna Phillips
P2860
P304
P356
10.1093/NEUONC/NOW282
P577
2017-02-28T00:00:00Z